Enliven Therapeutics, Inc (ELVN) Tops Q4 EPS by 6c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• A.O. Smith executive chairman to retire, CEO to assume chairman role
• Edgewell stock surges on report of rejected takeover bid